Orient New Life Medical Co.,Ltd.

Orient New Life Medical Co.,Ltd. Quality is life.

Manufacturer from China
Active Member
8 Years
Home / Products / Home Testing Kits /

4mm Cassette Home Testing Kits CE , Home Aids Test Kit For Carcinoembryonic Antigen

Contact Now
Orient New Life Medical Co.,Ltd.
City:ningbo
Province/State:zhejiang
Contact Person:MrJerry Meng
Contact Now

4mm Cassette Home Testing Kits CE , Home Aids Test Kit For Carcinoembryonic Antigen

Ask Latest Price
Video Channel
Brand Name :New Life
Model Number :Cassette
Certification :ISO13485,CE
Place of Origin :China
MOQ :5000pcs
Price :USD0.5-USD2
Payment Terms :T/T, Western Union
Supply Ability :2000000pcs/month
Delivery Time :20-30days
Packaging Details :1pc/pouch, 25pcs/box
Category :Home use
Format :cassette
Specimen :Whole Blood/Serum/Plasma
Testing time :5-15 minutes
Shelf Life :24 Months
Application :Carcinoembryonic Antigen home tesing
Cut-off :5ng/ml
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

Tumor Mark CEA Home Testing kits, 4mm cassette set, detecting Carcinoembryonic Antigen, home use

Product Name: CEA Rapid Diagnostic Test

Intended Use:

The CEA Home Testing kit is a rapid chromatographic immunoassay for the qualitative detection of CEA in whole blood, serum or plasma to aid in monitoring of cancer patients at home.

Summary:

Carcinoembryonic Antigen (CEA) is a tumor-associated antigen characterized as an oncofetal glycoprotein. CEA is expressed in a variety of malignancies, particularly pulmonary or gastrointestinal tumors (e.g. colon cancer, liver cancer and lung cancer). CEA normally occurs in fetal gut tissue with detectable serum levels essentially disappearing after birth.Therefore, elevated levels of CEA can be of significant value in the diagnosis of primary carcinomas. In addition to qualitative assessment, CEA testing plays an important role in the monitoring of cancer patients. Clinical evidence indicates that CEA levels can serve as predictive markers in both pre- and post-treatment cancer. Progressive elevation of CEA may signal tumor recurrence 3-36 months before clinical evidence of metastasis. Persistent elevation of circulating CEA following treatment is strongly indicative of occult metastatic and residual diseases and deficient therapeutic response. The CEA Rapid Test Cassette (Whole Blood/Serum/Plasma) utilizes a combination of anti-CEA antibody coated particles and anti-CEA antibodies to detect elevated levels of CEA in whole blood, serum or plasma. The minimum detection level is 5ng/ml.

TEST PROCEDURE

1. Bring the pouched test device to room temperature(15-30℃) prior to testing. Do not open the pouch until ready to begin testing.

2. Remove the device from the sealed pouch and lay it on a flat and dry surface.

3. Using the provided pipette, add one drop of fresh specimen to the sample well.

4. Hold the buffer bottle vertically and add 1 drop to the sample well. /If using a pipette, change a new one to avoid cross-contamination. Draw and transfer 2-3 drops of buffer to the sample well.

5. Read the result between 15-20minutes. Do not read results after 20 minutes.

PERFORMANCE CHARACTERS:

Sensitivity and Specificity

Clinical Performance For One Step CEA Test

A total of 223 patients was selected as participants in this study, the samples collected from these patients were tested by the RDTs and by a commercial Elisa Test. Comparison for all subjects is showed in the following table.

Table 2 

Accessed Test Alignment test
Positive Negative Total
Positive 90 3 93
Negative 4 126 130
Total 94 129 223

Sensitivity=[90/(90+4)]×100%=95.74%

Specialty=[126/(3+126) ]×100%=97.67%

Total=[(90+126)/(90+4+3+126)]×100%=96.86%

ORIENT NEW LIFE MEDICAL CO., LTD.
Contact: Jerry Meng
Email: Jerry @ newlifebiotest .com
Tel. +86 18657312116
SKYPE enetjerry
Inquiry Cart 0